Halozyme Therapeutics Competitors and Similar CompaniesClear all
Halozyme Therapeutics's competitors and similar companies include Partner Therapeutics, Verastem Oncology, Rakuten Medical, Agenus, Blueprint Medicines and Karyopharm Therapeutics.
 Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment. |  Partner Therapeutics Partner Therapeutics is developing and commercializing cancer medicines and combination therapies. |  Verastem Oncology Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. |  Rakuten Medical Rakuten Medical (formerly Rakuten Aspyrian) is a clinical stage biotechnology company developing tumor-targeted precision therapies. |  Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer. |  Blueprint Medicines Blueprint Medicines is a biopharmaceutical company engaged in developing therapies for allergy, inflammation, and oncology/hematology. |  Karyopharm Therapeutics Karyopharm Therapeutics is a commercial-stage pharmaceutical company that pioneers in cancer therapies. | |
Founding Date | Founding Date 1998 | Founding Date 2017 | Founding Date 2010 | Founding Date 2013 | Founding Date 1994 | Founding Date 2011 | Founding Date 2008 |
Type | Type Public | Type Private | Type Public | Type Private | Type Public | Type Public | Type Public |
Tags | |||||||
Locations | Locations San Diego, US HQ | Locations Lexington, US HQ Boston, US Lynnwood, US | Locations Needham, US HQ Walsrode, DE | Locations San Diego, US HQ Setagaya City, JP Amsterdam, NL Ecublens, CH Taipei, TW Taipei, TW San Mateo, US | Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US | Locations Cambridge, US HQ Amsterdam, NL Lugano, CH Zug, CH | Locations Newton, US HQ Givatayim, IL |
Employees | Employees 373157% increase | Employees 189 | Employees 7328% increase | Employees 1241% increase | Employees 8174% decrease | Employees 6552% increase | Employees 22818% decrease |
Valuation ($) | Valuation ($) 6.4 b | Valuation ($) N/A | Valuation ($) 144.9 m | Valuation ($) N/A | Valuation ($) 96.2 m | Valuation ($) 5.3 b | Valuation ($) 111.7 m |
Financial | |||||||
Revenue (est.) | Revenue (est.) $1.4b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $30.9m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $114.2m (FY, 2025) | Revenue (est.) $508.8m (FY, 2024) | Revenue (est.) $146.1m (FY, 2025) |
Cost of goods | Cost of goods $228.8m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $1m (FY, 2025) | Cost of goods $20.2m (FY, 2024) | Cost of goods $5.9m (FY, 2025) |
Gross profit | Gross profit $1.2b (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit $113.2m (FY, 2025) | Gross profit $488.7m (FY, 2024) | Gross profit $140.1m (FY, 2025) |
Net income | Net income $316.9m (FY, 2025) | Net income N/A | Net income ($209.5m) (FY, 2025) | Net income N/A | Net income ($3.1m) (FY, 2025) | Net income ($67.1m) (FY, 2024) | Net income ($196m) (FY, 2025) |
Operating ⚠ | |||||||
Phase II Trials Products | Phase II Trials Products 1 (FY, 2020) | Phase II Trials Products N/A | Phase II Trials Products 4 (FY, 2020) | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A |
Funding | |||||||
Latest funding round | Latest funding round N/A | Latest funding round $ 60m (over 8 years ago) | Latest funding round N/A | Latest funding round $ 100m (almost 7 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 171.9m | Total funding raised $ 60m | Total funding raised $ 170m | Total funding raised $ 451.9m | Total funding raised $ 171.1m | Total funding raised $ 1.7b | Total funding raised $ 248.7m |
For sources of this data, please see the company profile
View Company Profiles
Partner Therapeutics
HQ
Lexington, US
Employees
189
Partner Therapeutics is developing and commercializing cancer medicines and combination therapies.
View companyVerastem Oncology
HQ
Needham, US
Employees
73↑ 28% increase
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer.
View companyRakuten Medical
HQ
San Diego, US
Employees
124↑ 1% increase
Rakuten Medical (formerly Rakuten Aspyrian) is a clinical stage biotechnology company developing tumor-targeted precision therapies.
View companyAgenus
HQ
Lexington, US
Employees
81
Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.
View company